Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01205815

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Melanoma Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Neuroectodermal Tumors Neuroendocrine Tumors Nevi and Melanomas Skin Diseases Skin Neoplasms Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Vanderbitl-Ingram Cancer Center

Nashville, Tennessee, United States

Location status: Recruiting

Location contact

Douglas Johnson, MD

PRINCIPAL_INVESTIGATOR

Vanderbilt-Ingram Service for Timely Access

CONTACT

800-811-8480

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pathologically-proven diagnosis of melanoma.
  • Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.

Exclusion criteria

  • Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.
  • Any patient unable or unwilling to provide consent.

Treatment and study plan

Tissue and blood collection

Other

Tissue will be obtained from a previous biopsy if available, or if unavailable, tissue will be collected from a scheduled biopsy. About3-4 teaspoons of blood will be collected.

Primary outcomes

  1. Molecular changes in patients' melanoma tissue

    Time frame: at 120 months

    Tissue is collected upon consent or upon receipt of parafin block, primary aim will be met when all tissues are collected and analyzed at conclusion of study. Intent is to aid patients and their treating physician when making treatment decisions.

Secondary outcomes

  1. Improve the time between ordering the test and results entry into medical records

    Time frame: 120 months

    To enhance the speed and detail of molecular mutation profiling of melanoma

Study contacts

Contact information is provided by the study sponsor or research team.

Vanderbilt-Ingram Service for Timely Access

CONTACT

800-811-8480

Sponsors and collaborators

Lead sponsor

Vanderbilt-Ingram Cancer Center

Other

Registry information

Important dates

Study start
2010
Primary completion
2027
Study completion
2027
First posted
Sep 21, 2010
Registry last updated
Sep 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.